Latest News & Features
Americas
Law firm Orrick, Herrington & Sutcliffe has added Richard DeLucia, Elizabeth Gardner, Antony Pfeffer and Patrick Herman to the firm’s patent litigation group in New York. 12 January 2016
Americas
Biopharmaceutical company Shire has completed the $32 billion takeover of US-based Baxalta 11 January 2016
Africa
Intellectual property rights should be used to help valorise agricultural biodiversity and traditional knowledge for the benefit of the global population as well as small farming communities around the world, says Graham Dutfield of the University of Leeds. 11 January 2016
Europe
US-based gene sequencing company Illumina has claimed that The Doctors Laboratory’s use of the Harmony prenatal test provided by Ariosa Diagnostics infringes its patent. 8 January 2016
Americas
Enzo Biochem has agreed a $9 million settlement with Agilent Technologies in a patent infringement lawsuit centring on technology used in detecting nucleic acid. 7 January 2016
Americas
The manner in which some Canadian judges have applied the ‘promise’ doctrine has been criticised as arbitrary and subjective, note Declan Hamill and Megan Kendall of Innovative Medicines Canada, the association of Canada’s innovative pharmaceutical industry. 7 January 2016
Americas
A US district court has ordered a stay in a patent infringement case between Jawbone and Fitbit as the International Trade Commission is due to issue its ruling on another case centring on the same patents. 6 January 2016
Americas
Biopharmaceutical company Celgene and India-based rival Natco Pharma have settled a lawsuit centring on the alleged infringement of a number patents covering the Revlimid drug. 5 January 2016
Biotechnology
A grace period would give German inventors more flexibility to deal with different rules set by scientific publications and patenting procedures, and allow them to seek patent rights without the fear of prior disclosure, as Michael Kahnert of BIO Deutschland reports. 5 January 2016
Americas
Biopharmaceutical company Suven Life Sciences has been granted three product patents for the non-chemical entities for the treatment of neurodegenerative diseases including Alzheimer’s. 5 January 2016